Safety and Efficacy of AQW051 in L-dopa Induced Dyskinesias in Patients With Parkinson's Disease
Clinical trial NCT01474421 · COMPLETED
Trial details
- NCT number
- NCT01474421
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-15
- Primary completion
- 2013-02-21
- Enrollment
- 71
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.